IRIS
FILOMIA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 638
NA - Nord America 509
AS - Asia 135
Totale 1.282
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 508
PL - Polonia 208
IE - Irlanda 182
SE - Svezia 111
IT - Italia 99
CN - Cina 81
IN - India 20
SG - Singapore 17
VN - Vietnam 12
BE - Belgio 11
DE - Germania 8
FI - Finlandia 6
GB - Regno Unito 6
IR - Iran 3
CZ - Repubblica Ceca 2
FR - Francia 2
BD - Bangladesh 1
BY - Bielorussia 1
CA - Canada 1
HR - Croazia 1
KW - Kuwait 1
NO - Norvegia 1
Totale 1.282
Salva come PNG Salva come JPEG
Città #
Warsaw 208
Dublin 182
Chandler 139
Nyköping 87
Ashburn 42
Messina 42
Dearborn 40
Ann Arbor 35
Princeton 22
Medford 20
Jacksonville 15
Des Moines 14
Cambridge 13
Beijing 12
Dong Ket 12
Brussels 11
Hyderabad 11
Nanjing 11
Seattle 11
Jinan 10
Avola 9
Catania 9
Singapore 9
Pune 7
Boardman 6
Bremen 6
San Mateo 6
Wilmington 6
Haikou 5
New York 5
Shenyang 5
Cagliari 4
Guangzhou 4
Hangzhou 4
Hebei 4
Nanchang 4
Rome 4
Tianjin 4
Woodbridge 4
Zhengzhou 4
Ningbo 3
Brno 2
Dundee 2
Houston 2
Jiaxing 2
Kunming 2
Lanzhou 2
Los Angeles 2
Naples 2
Nuremberg 2
Pachino 2
Rasht 2
Sortino 2
Trecastagni 2
Alcamo 1
Chengdu 1
Ferentino 1
Fuzhou 1
Kuwait City 1
Latina 1
Minsk 1
Modica 1
Montréal 1
Niscemi 1
Oslo 1
Padula 1
Palermo 1
Piazza Armerina 1
Redwood City 1
Rosolini 1
Taizhou 1
Tehran 1
Washington 1
Yicheng 1
Zagreb 1
Totale 1.096
Salva come PNG Salva come JPEG
Nome #
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma development and death in patients with compensated cirrhosis 222
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 104
Atrial fibrillation in patients with cirrhosis 96
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 94
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 78
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 68
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 66
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 60
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 55
Low prevalence of hepatitis B and hepatitis C virus serum markers in a cohort of pregnant women from Southern Italy 51
Mucocutaneous toxicity during simeprevir treatment for hepatitis C. A single institution, retrospective case series 43
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 43
Occult HBV infection 40
Erectile dysfunction in compensated liver cirrhosis 40
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 39
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 39
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 37
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 36
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 34
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 25
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis 23
null 22
null 19
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 15
Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy 6
RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study 5
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 5
Totale 1.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020152 1 5 6 2 14 39 18 11 8 23 12 13
2020/2021226 9 10 42 8 41 8 19 29 13 32 3 12
2021/2022165 6 15 5 7 15 0 19 9 0 13 25 51
2022/2023492 36 65 18 38 28 45 11 29 208 4 8 2
2023/2024149 12 14 8 19 15 26 1 12 0 20 4 18
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 1.365